Chemical Structure : MA191
Catalog No.: PC-28746Not For Human Use, Lab Use Only.
MA191 is a potent, von Hippel-Lindau (VHL) E3 ubiquitin ligase-based PROTAC degrader of FLT3 with DC50 of 10 nM, also degrades MAPK14 (p38α).
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MA191 is a potent, von Hippel-Lindau (VHL) E3 ubiquitin ligase-based PROTAC degrader of FLT3 with DC50 of 10 nM, also degrades MAPK14 (p38α).
MA191 demonstrate superior degradation of FLT3-ITD in MV4-11 AML cells at 50 nM, achieving >95% reduction in FLT3-ITD levels.
MA191 induces apoptosis in cultured and primary AML patient cells harboring FLT3-ITD (IC50=9.6-11 nM, EC50=0.001-0.883 µM).
MA191 requires VHL, neddylation, proteasome activity, and the pro-apoptotic BH3-only protein BIM.
MA191 reduces FLT3-ITD prior to apoptosis, uncovering apoptosis-independent roles of BIM for protein stability.
MA191 also depletes MAPK14 in FLT3 negative K562 chronic myeloid leukemia cells, in RS4-11 acute T cell lymphatic leukemia cells with wild-type FLT3, and in MV4-11 and MOLM-13 cells.
| M.Wt | 1088.34 | |
| Formula | C57H73N11O9S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Melisa Halilovic, et al. Leukemia. 2026 Oct 28. doi: 10.1038/s41375-026-03168-x.
2. Abdelsalam M, et al. Pharmaceuticals (Basel). 2026 May 12;19(5):756.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright